Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06734975
PHASE2

Effect of Superior Laryngeal Nerve Blocks on Patient Outcomes in Laryngeal Surgery

Sponsor: Rutgers, The State University of New Jersey

View on ClinicalTrials.gov

Summary

Patients undergoing surgery on their vocal cord will either receive a numbing injection to their throat or a saline injection during surgery. Symptoms such as how much coughing or pain patients have after surgery, as well as whether patient's voice gets better will be interrogated.

Official title: Effect of Intraoperative Superior Laryngeal Nerve Blocks on Patient Outcomes in Microdirect Laryngoscopy for Benign Vocal Fold Lesions: A Randomized Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

28

Start Date

2025-07-11

Completion Date

2026-12

Last Updated

2026-01-15

Healthy Volunteers

No

Interventions

DRUG

Superior laryngeal nerve block - Intervention (Bupivacaine and triamcinolone acetonide suspension)

Patients will receive a superior laryngeal nerve block consisting of 1 ml of 0.25% bupivacaine and 1mL of triamcinolone acetate 40 mg/ml to the neck on the side of the vocal cord lesion during their surgery.

DRUG

Superior laryngeal nerve block - Placebo (saline)

Patients will receive a saline placebo of 2mL saline to the neck on the side of the vocal cord lesion during their surgery.

Locations (1)

Rutgers New Jersey Medical School

Newark, New Jersey, United States